Frequency of CD4⁺CXCR5⁺CD127^(lo) TFR cells in patients with rheumatoid arthritis
Clinical Rheumatology · 2026-12 · 45 (12) · 7271-7280
DOI: 10.1007/s10067-026-08490-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Rheumatology, online erschienen am 31.10.2026. Verfasst von Rong Huang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, The People's Hospital of Yuhuan, Taizhou City, Zhejiang Province, China. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, T-Lymphocytes, Regulatory, CD4-Positive T-Lymphocytes. Die Arbeit nennt 42 Literaturangaben. Gefördert von: Science and Technology Plan Project of Taizhou.
Abstract (Originalsprache)
Introduction
Dysregulation of Tfh and Tfr cells has been identified in rheumatoid arthritis (RA), yet inconsistent findings remain across existing studies. Accordingly, we investigated peripheral blood lymphocytes, CD4⁺ T cells, Treg, Tfh and Tfr subsets in untreated RA patients, treated RA patients and healthy controls to clarify their dynamic alterations in RA progression.
Methods
A total of 27 newly diagnosed, untreated RA patients (N-RA), 10 matched treated RA patients (P-RA) and 14 healthy controls (HCs) were included. Peripheral blood proportions of lymphocytes, CD4⁺ T cells, Treg, Tfh and Tfr were determined by flow cytometry, while serum Fgl2 levels were measured via ELISA. Intergroup differences in these markers were subsequently analyzed.
Results
Fgl2 levels were significantly higher in the RA group than in HCs (20.74% vs. 13.90%, P = 0.002), whereas no statistically significant differences were observed across the three groups (N-RA, P-RA and HCs).Tfr frequencies were notably higher in N-RA patients than in P-RA (4.56% vs 3.16%, P = 0.001) and HCs (4.56% vs 2.81%, P < 0.001), with no obvious difference between P-RA and HCs. Consistent results were detected in paired pre- and post-treatment RA samples (4.99% vs 3.01%, P = 0.015). Tfr proportions showed no obvious correlations with clinical parameters.
Conclusion
Fgl2 may not serve as an ideal biomarker for RA. The frequency of Tfr cells was notably elevated in N-RA patients and declined significantly following therapeutic intervention. Given the absence of significant correlations between Tfr levels and clinical indicators, we hypothesized that anti-rheumatic therapy could normalize elevated Tfr levels. Key Points • Tfr cells are significantly increased in newly diagnosed RA. • Anti-rheumatic therapy significantly corrects the imbalance of Tfr cells in RA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, The People's Hospital of Yuhuan, Taizhou City, Zhejiang Province, China.
- Department of Rheumatology and Immunology, The People's Hospital of Yuhuan, Taizhou City, Zhejiang Province, China.
- Department of Blood Transfusion, The People's Hospital of Yuhuan, Taizhou City, Zhejiang Province, China.
- Department of Rheumatology and Immunology, The People's Hospital of Yuhuan, Taizhou City, Zhejiang Province, China. whitehorse818@163.com.
- The People's Hospital of Yuhuan, Taizhou City, Zhejiang Province, China. zlhjy@126.com.
Förderung
- Science and Technology Plan Project of Taizhou
Zitieren
APA
Huang, R., Chen, X., Wang, P., Liang, L., Chen, L., Guo, Y., Lin, G., Lin, C., & Zhang, L. (2026). Frequency of CD4⁺CXCR5⁺CD127^(lo) TFR cells in patients with rheumatoid arthritis. Clinical Rheumatology, 45(12), 7271-7280. https://doi.org/10.1007/s10067-026-08490-4
Vancouver
Huang R, Chen X, Wang P, Liang L, Chen L, Guo Y, et al. Frequency of CD4⁺CXCR5⁺CD127^(lo) TFR cells in patients with rheumatoid arthritis. Clinical Rheumatology. 2026;45(12):7271-7280. doi:10.1007/s10067-026-08490-4
BibTeX
@article{Huang2026,
author = {Huang, Rong and Chen, Xianhong and Wang, Ping and Liang, Lili and Chen, Lingcai and Guo, Yanfeng and Lin, Guo and Lin, Chenping and Zhang, Linhua},
title = {Frequency of CD4⁺CXCR5⁺CD127^(lo) TFR cells in patients with rheumatoid arthritis},
journal = {Clinical Rheumatology},
year = {2026},
volume = {45},
number = {12},
pages = {7271--7280},
doi = {10.1007/s10067-026-08490-4}
}
EUVIMED